Interactions of the C2 domain of human factor V with a model membrane

Proteins: Structure, Function and Genetics

Volumn 64, Issue 2, 2006, Pages 363-375

  Mollica, Luca ^a   Fraternali, Franca ^b,c   Musco, Giovanna ^a  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Domain C2 of coagulation Factor V; Molecular dynamics; Peripheral membrane protein; POPE

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 5; PHOSPHATIDYLSERINE; PHOSPHOLIPID; WATER;

ARTICLE; ARTIFICIAL MEMBRANE; BLOOD CLOTTING; COMPLEX FORMATION; ENERGY TRANSFER; ENZYME MECHANISM; HYDROGEN BOND; MEMBRANE BINDING; MOLECULAR DYNAMICS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; SIMULATION; X RAY CRYSTALLOGRAPHY;

CELL MEMBRANE; ELECTROSTATICS; FACTOR V; HUMANS; HYDROGEN BONDING; LIPID BILAYERS; MODELS, MOLECULAR; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; WATER;

EID: 33745603727     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.20986     Document Type: Article

References (65)

1. Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of Factor V in human plasma and platelets. Blood 1982;60:59-63.
2. Kane WH, Davie EW. Blood coagulation Factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988;71:539-555.
3. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003;42:423-438.
4. Esmon CT. The subunit structure of thrombin-activated Factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 1979;254:964-973.
5. Krishnaswamy S, Russell GD, Mann KG. The reassociation of Factor Va from its isolated subunits. J Biol Chem 1989;264:3160-3168.
6. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979;254:10952-10962.
7. Peng W, Quinn-Allen MA, Kim SW, Alexander KA, Kane WH. Trp2063 and Trp2064 in the Factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex. Biochemistry 2004;43:4385-4393.
8. Ortel TL, Devore-Carter D, Quinn-Allen M, Kane WH. Deletion analysis of recombinant human Factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem 1992;267:4189-4198.
9. Kim SW, Quinn-Allen MA, Camp JT, Macedo-Ribeiro S, Fuentes-Prior P, Bode W, Kane WH. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanningmutagenesis. Biochemistry 2000;39:1951-1958.
10. Nicolaes GA, Villoutreix BO, Dahlback B. Mutations in a potential phospholipid binding loop in the C2 domain of Factor V affecting the assembly of the prothrombinase complex. Blood Coagul Fibrinolysis 2000;11:89-100.
11. Srivastava A, Quinn-Allen MA, Kim SW, Kane WH, Lentz BR. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human Factor Va. Biochemistry 2001;40:8246-8255.
12. Kalafatis M, Rand MD, Mann KG. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 1994;33:486-493.
13. Saleh M, Peng W, Quinn-Allen MA, Macedo-Ribeiro S, Fuentes-Prior P, Bode W, Kane WH. The Factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of Factor V using alanine scanningmutagenesis. Thromb Haemost 2004;91:16-27.
14. Peng W, Quinn-Allen MA, Kane WH. Mutation of Hydrophobic residues in the Factor Va C1 and C 2 domains blocks membrane-dependent prothrombin activation. J Thromb Haemost 2005;3:351-354.
15. Ortel TL, Moore KD, Quinn-Allen MA, Okamura T, Sinclair AJ, Lazarchick J, Govindan R, Carmagnol F, Kane WH. Inhibitory anti-Factor V antibodies bind to the Factor V C2 domain and are associated with hemorrhagic manifestations. Blood 1998;91:4188-4196.
16. Macedo-Ribeiro S, Bode W, Huber R, Quinn-Allen MA, Kim SW, Ortel TL, Bourenkov GP, Bartunik HD, Stubbs MT, Kane WH, Fuentes-Prior P. Crystal structures of the membrane-binding C2 domain of human coagulation Factor V. Nature 1999;402:434-439.
17. Baumgartner S, Hofmann K, Chiquet-Ehrismann R, Bucher P. The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci 1998;7:1626-1631.
18. Ortel TL, Devore-Carter D, Quinn-Allen M, Kane WH. Deletion analysis of recombinant human Factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem 1992;267:4189-4198.
19. Cutsforth GA, Koppaka V, Krishnaswamy S, Wu JR, Mann KG, Lentz BR. Insights into the complex association of bovine Factor Va with acidic-lipid-containing synthetic membranes. Biophys J 1996;70:2938-2949.
20. Koppaka V, Lentz BR. Binding of bovine Factor Va to phosphatidylcholine membranes. Biophys J 1996;70:2930-2937.
21. Ash WL, Zlomislic MR, Oloo EO, Tieleman DP. Computer simulations of membrane proteins. Biochim Biophys Acta 2004;1666:158-189.
22. Shih AY, Denisov IG, Phillips JC, Sligar SG, Schulten K. Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins. Biophys J 2005;88:548-556.
23. Aliste MP, MacCallum JL, Tieleman DP. Molecular dynamics simulations of pentapeptides at interfaces: salt bridge and cation-Pi interactions. Biochemistry 2003;42:8976-8987.
24. Tieleman DP, Hess B, Sansom MS. Analysis and evaluation of channel models: simulations of alamethicin. Biophys J 2002;83:2393-2407.
25. Vaccaro L, Cross KJ, Kleinjung J, Straus SK, Thomas DJ, Wharton SA, Skehel JJ, Fraternali F. Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers. Biophys J 2005;88:25-36.
26. Tieleman DP, Forrest LR, Sansom MS, Berendsen HJ. Lipid properties and the orientation of aromatic residues in OmpF, influenza M2, and alamethicin systems: molecular dynamics simulations. Biochemistry 1998;37:17554-17561.
27. Malmberg NJ, Falke JJ. Use of EPR power saturation to analyze the membrane-docking geometries of peripheral proteins: applications to C2 domains. Annu Rev Biophys Biomol Struct 2005;34:71-90.
28. Tieleman DP, Berendsen HJ. A molecular dynamics study of the pores formed by Escherichia coli OmpF porin in a fully hydrated palmitoyloleoylphosphatidylcholine bilayer. Biophys J 1998;74:2786-2801.
29. Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comp Phys Comm 1995;91:43-56.
30. van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG. Biomolecular simulation: the GROMOS96 manual and user guide. Zurich: Hochschulverlag; 1996.
31. Berger O, Edholm O, Jahnig F. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. Biophys J 1997;72:2002-2013.
32. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690.
33. Hess B, Bekker H, Berendsen HJC, Fraaije J. LINGS: a linear constraint solver for molecular simulations. J Comput Chem 1997;18:1463-1472.
34. Hermans J, Berendsen HJC, van Gunsteren WF, Postma JPM. A consistent empirical potential for water protein interactions. Biopolymers 1984;23:1513-1518.
35. Zwaal RF, Comfurius P, Bevers EM. Lipid-protein interactions in blood coagulation. Biochim Biophys Acta 1998;1376:433-453.
36. Virtanen JA, Cheng KH, Somerharju P. Phospholipid composition of the mammalian red cell membrane can be rationalized by a super-lattice model. Proc Natl Acad Sci U S A 1998;95:4964-4969.
37. Kandall CL, Shohet SB, Akinbami TK, Colman RW. Determinants of the formation and activity of Factor V-phospholipid complexes. II. Molecular properties of the complexes. Thromb Diath Haemorrh 1975;34:271-284.
38. Faraldo-Gomez JD, Smith GR, Sansom MS. Setting up and optimization of membrane protein simulations. Eur Biophys J 2002;31:217-227.
39. Domene C, Bond PJ, Deol SS, Sansom MS. Lipid/protein interactions and the membrane/water interfacial region. J Am Chem Soc 2003;125:14966-14967.
40. Stoylova S, Mann KG, Brisson A. Structure of membrane-bound human Factor Va. FEBS Lett 1994;351:330-334.
41. Gawrisch K, Koenig BW. Lipid-peptide interactions investigated by NMR. Curr Topics Membranes 2002;52:163-190.
42. Fraternali F, Cavallo L. Parameter optimized surfaces (POPS): analysis of key interactions and conformational changes in the ribosome. Nucleic Acids Res 2002;30:2950-2960.
43. Kleinjung J, Fraternali F. POPSCOMP: an automated interaction analysis of biomolecular complexes. Nucleic Acids Res 2005;33:W342-346.
44. Miteva MA, Brugge JM, Rosing J, Nicolaes GA, Villoutreix BO. Theoretical and experimental study of the D2194G mutation in the C2 domain of coagulation Factor V. Biophys J 2004;86:488-498.
45. White SH, Wimley WC. Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct 1999;28:319-365.
46. Petrache HI, Grossfield A, MacKenzie KR, Engelman DM, Woolf TB. Modulation of glycophorin A transmembrane helix interactions by lipid bilayers: molecular dynamics calculations. J Mol Biol 2000;302:727-746.
47. Berneche S, Nina M, Roux B. Molecular dynamics simulation of melittin in a dimyristoylphosphatidylcholine bilayer membrane. Biophys J 1998;75:1603-1618.
48. Stone MD, Nelsestuen GL. Efficacy of soluble phospholipids in the prothrombinase reaction. Biochemistry 2005;44:4037-4041.
49. Pellequer JL, Gale AJ, Griffin JH, Getzoff ED. Homology models of the C domains of blood coagulation Factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol Dis 1998;24:448-461.
50. Pellequer JL, Gale AJ, Getzoff ED, Griffin JH. Three-dimensional model of coagulation Factor Va bound to activated protein C. Thromb Haemost 2000;84:849-857.
51. Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. The phosphatidylserine binding site of the Factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex. Biochemistry 2005;44:711-718.
52. Lecompte MF, Bouix G, Mann KG. Electrostatic and hydrophobic interactions are involved in Factor Va binding to membranes containing acidic phospholipids. J Biol Chem 1994;269:1905-1910.
53. Kim SW, Quinn-Allen MA, Camp JT, et al. Identification of functionally important amino acid residues within the C2-domain of human Factor V using alanine-scanning mutagenesis. Biochemistry 2000;39:1951-1958.
54. Mukhopadhyay P, Monticelli L, Tieleman DP. Molecular dynamics simulation of a palmitoyl-oleoyl phosphatidylserine bilayer with Na+ counterions and NaCl. Biophys J 2004;86:1601-1609.
55. Yau WM, Wimley WC, Gawrisch K, White SH. The preference of tryptophan for membrane interfaces. Biochemistry 1998;37:14713-14718.
56. Granseth E, von Heijne G, Elofsson A. A study of the membrane-water interface region of membrane proteins. J Mol Biol 2005;346:377-385.
57. Peng W, Quinn-Allen MA, Kim SW, Alexander KA, Kane WH. Trp2063 and Trp2064 in the Factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex. Biochemistry 2004;43:4385-4393.
58. Stahelin RV, Cho W. Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2. Biochemistry 2001;40:4672-4678.
59. Chamberlain AK, Lee Y, Kim S, Bowie JU. Snorkeling preferences foster an amino acid composition bias in transmembrane helices. J Mol Biol 2004;339:471-479.
60. Strandberg E, Killian JA. Snorkeling of lysine side chains in transmembrane helices: how easy can it get? FEBS Lett 2003;544:69-73.
61. Stahelin RV, Cho W. Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2. Biochemistry 2001;40:4672-4678.
62. Adams TE, Hockin MF, Mann KG, Everse SJ. The crystal structure of activated protein C-inactivated bovine factor Va: implications for cofactor function. Proc Natl Acad Sci U S A 2004;101:8918-8923.
63. Spiegel PC, Kaiser SM, Simon JA, Stoddard BL. Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII. Chem Biol 2004;11:1413-1422.
64. Lensink MF, Christiaens B, Vandekerckhove J, Prochiantz A, Rosseneu M. Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. Biophys J 2005;88:939-952.
65. Garemyr R, Elofsson A. Study of the electrostatics treatment in molecular dynamics simulations. Proteins 1999;37:417-428.